Clinical Trial Update: RLIP76 in Human Serum in Adults With Rheumatologic Diseases

View source ↗

Summary

A clinical trial evaluating RLIP76 in human serum in adults with rheumatologic diseases, focusing on carotid atherosclerosis, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Atherosclerosis

Snippet

Sponsor: University of North Texas Health Science Center | Conditions: Carotid Atherosclerosis | Status: WITHDRAWN